Recombinant SARS-CoV-2 Nucleocapsid Protein produced in E.coli is a Recombinant His-tagged protein.
Recombinant SARS-CoV-2 Nucleocapsid Protein
Description
SARS-CoV-2 nucleocapsid (N) protein is an important antigen for coronavirus, which participates in RNA package and virus particle release.
Nucleocapsid protein packages the positive strand viral RNA genome into a helical interactions with the viral genome and the small membrane protein M. It plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Nucleocapsid protein may modulate the transforming growth factor-beta signalling by binding host smad3.
Additional information
Size | 100 µg |
---|---|
Application | Clinical diagnostics| Life Sciences |
Product type | Reagents for research |
Reagent type | Recombinant protein |
Category | Covid 19 |
Subcategory | Nucleocapsid Protein |
Technical information
Accession number | UniProt QHD43423.2 |
---|---|
Organism | SARS-CoV-2 |
Size | 100 µg |
Potency | Not biologically Active protein |
Expression system | E.coli |
Tag | His-tagged |
Purity | >90% |
Form | Liquid |
Tested application | SDS-PAGE |
Shipping/storage conditions | Shipped on dry ice. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles |
Usage | For Laboratory research only |
Download
References
A new coronavirus associated with human respiratory disease in China. | PUMED ID: 32015508 |
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. | PUBMED ID: 32363136 |
Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein. | PUBMED ID: 32511359 |